The first placebo-controlled study of mavrilimumab in this setting supports further investigation of monoclonal antibodies targeting GM-CSF to attenuate overactive inflammatory response in COVID-19.
Reasons for lagging COVID-19 vaccination rates among Black Americans are likely multifactorial. Likewise, responses to promote vaccination need to be multifaceted and community-based.
We share our experience providing safe and routine access to phase II cardiac rehabilitation to patients across nine regional cardiac rehab centers using inclusive telemedicine methods and resourceful center-based care.
In March 2020, the mortality rates of patients with COVID-19 at Cleveland Clinic were significantly higher than non-COVID patients. But by June 2020, there was no statistical difference between the patient groups. Critical care physicians discuss the system-wide strategies likely attributable to these improved outcomes.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Technology-driven automation has ensured that Cleveland Clinic is able to vaccinate as many people as possible all while navigating a difficult landscape.
A Cleveland Clinic rhinologist discusses potential treatment methods for one of the most common side-effects of COVID-19.
In addition to producing potent neutralizing antibodies, the candidate vaccine may not require strict temperature control. Progress toward human studies continues.
This visual tracker of COVID-19 case and mortality data is updated daily to keep you abreast of national and state-by-state trends in the pandemic’s epidemiology.
Higher NAb levels provided protection against illness and transmission in study models.
1 in 5 adults in the U.S. reported their household members were unable to get, or delayed getting, medical care for serious problems during the COVID-19 pandemic. In this article, Chief of Staff Beri Ridgeway, MD, explores non-pandemic access issues.